A European network dedicated to connecting patients
What can EPROPA do for me?
A growing community
Leveraging scientific networking, physicians joining to this project will experience the chance to discuss molecular data and treatment options.
Clinical trials
As of September 2020Admitted patients
Would you like to know more?
If you are interested in this specific project, please "CONTACT WALCE" to gain more information and directly ask opportunities to proceed or call at he WALCE Office: +39-0119026980
A structured network of institutions and companies
The aim of EPROPA is to create a European Research Network, involving Centers of Expertise in the treatment of lung cancer, different Pharma Companies and other entities, named the University of Turin and the International Association for the Study of Lung Cancer (IASLC) that have endorsed this program.
The Pharma Companies that support EPROPA are
How doctors welcome EPROPA
"A year has already gone since the launch of the EPROPA program and we are pleased to close 2021, announcing a new center has obtained the Ethics Committee approval and will therefore be part of this network together. So Slovakia is joining Italy, Greece, Romania and Slovenia, where several centers are already active and offer this opportunity to their patients. As always, many patients have contacted us, always involving the centers of reference and we are pleased to have been of support in the diagnostic and therapeutic approach. During this year we have been able to identify target molecular alterations in many of the samples examined and the number of patients benefiting from EPROPA, by accessing a clinical trial available in another center, on the basis of the analyzes carried out, has increased and at the moment we have 6 people”
Prof. Silvia Novello
President WALCE and Head of Thoracic Oncology Unit - San Luigi Hospital Orbassano/Turin – Italy
About WALCE
WALCE (Women Against Lung Cancer in Europe) is a non-profit Organisation based in Italy and networking at European level, founded in 2006 with the primary aim to increase women’s awareness about the significant incidence and mortality of lung cancer in female population and to support patients affected by this disease (and their families). WALCE currently provides accurate and updated information about lung cancer in terms of prevention, diagnosis and treatment, and it wants to promote communication strategies aim to aware public opinion and decision makers on damages of smoking. WALCE is mainly involved in: information and education dedicated to patients and their families, patient support programs and primary prevention.
Visit website